Venrock Healthcare Capital Partners III, L.P. bought LYCA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001231919-26-001536

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 2, 2026

Published

Nov 4, 2026

Ingested by INSIDER

Nov 4, 22:39 UTC

Last re-read

Nov 4, 23:10 UTC

Extracted facts

Filer

Venrock Healthcare Capital Partners III, L.P.

Role

10% Owner

Transaction

Open-market purchaseAs filed: “P”

Asset

Lycia Therapeutics, Inc.

Ticker

LYCA

Shares

8,305

Price per share

$26.95

Value

$223,820

Execution date (reported)

Nov 2, 2026

Owned after transaction

6.86M shares

Days from execution to publication

2

Calculation

What this establishes

Venrock Healthcare Capital Partners III, L.P. filed this Form 4 reporting a open-market purchase of LYCA on Nov 2, 2026. It became public on Nov 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

10% Owner

Venrock Healthcare Capital Partners III, L.P.cik:0001738048

Issuer

Lycia Therapeutics, Inc.cik:0001806540

Revision history · 0

No field has changed since this record was first ingested.